HER2, showing improved event-free and overall survival in lung metastatic osteosarcoma. The start-up, which joined JLABS and ...

Swedish immuno-oncology firm Alligator Bioscience saw its shares jump more than 13% to 0.26 kronor this morning, as it ...

UK clinical-stage specialty pharma firm Actimed Therapeutics has appointed Dr Fabio Dorigotti as chief medical officer (CMO) ...

Formycon and Fresenius Kabi secure UK approval for Otulfi, a ustekinumab biosimilar targeting inflammatory conditions.

Owlstone Medical secures $27M in series E funding to advance breath-based diagnostics and commercialization. Led by Ventura ...

CR Pharmaceutical and NAMI collaborate to explore palbociclib’s potential for Alzheimer’s treatment, leveraging ...

US clinical-stage pharma Keros Therapeutics today announced that it has voluntarily halted all dosing in the TROPOS trial, a ...

Boston, USA-based Verastem Oncology today announced the appointment of Matthew Ros as chief operating officer (COO). In his ...

Eli Lilly saw its shares close down 6.6% at $744.91 yesterday, after it revealed forecast for sales at the JP Morgan ...

Cases of avian influenza A (H5N1) continue to rise among cattle and humans in the USA. Scientists and government health ...

Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a ...

Belgian drugmaker UCB has presented what it calls its ‘growth journey’ and the strategic priorities driving future success at ...